Webinar wrap-up: How pharma can leverage AI-driven synthetic...
Synthetic personas turn static, traditional personas into interactive, evidence-backed simulations.
Newsletters and Deep Dive digital magazine
Synthetic personas turn static, traditional personas into interactive, evidence-backed simulations.
EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.
Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.
It goes without saying that healthcare is in the midst of a digital, AI-accelerated transformation.
Pharma companies are turning to digital opinion leaders (DOLs) to fight misconceptions, raise disease awareness, and promote their products.
Editor's Picks
Newsletters and Deep Dive
digital magazine